• FirefoxUpgrade to the new Firefox »
  •  Dow Down 1.45% Nasdaq Down 1.03%

    Gilead Sciences Inc. (GILD)

    -NasdaqGS
    104.83 Up 0.65(0.62%) 4:00PM EST
    |After Hours : 105.02 Up 0.19 (0.18%) 7:51PM EST
    Add to Portfolio
    Prev Close:104.18
    Open:104.53
    Bid:105.08 x 500
    Ask:N/A
    1y Target Est:122.58
    Beta:1.18
    Next Earnings Date: 3-Feb-15GILD Earnings announcement
    Day's Range:103.73 - 106.27
    52wk Range:63.50 - 116.83
    Volume:13,608,217
    Avg Vol (3m):17,202,800
    Market Cap:158.15B
    P/E (ttm):18.68
    EPS (ttm):5.61
    Div & Yield:N/A (N/A)
    Quotes delayed, except where indicated otherwise. Currency in USD.

    Related Video

    Comparison

    Symbol% ChgMkt Cap
    GILDUp 0.62%158.15B
    GSKDown 2.57%105.78B
    PFEDown 1.82%196.90B
    RHHBYDown 1.79%N/A

    Key Statistics

    Forward P/E (1 yr):10.73
    P/S (ttm):7.59
    Ex-Dividend Date:N/A

    Analysts

    Annual EPS Est (Dec-14) :7.90
    Quarterly EPS Est (Dec-14) :2.20
    Mean Recommendation*:1.8
    PEG Ratio (5 yr expected):0.39

    * (Strong Buy) 1.0 - 5.0 (Sell)

    Analyst Opinion | Estimates

    Business Summary

    Gilead Sciences, Inc., a biopharmaceutical company, discovers, develops, and commercializes medicines for the treatment of life threatening diseases in North America, South America, Europe, and the Asia-Pacific. View More
    Your browser doesn't support canvas
    SETTINGS
    Scrolling
    Speed
    Display
    Price
    Submit Feedback